[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes one medical product company Lee Silsby Compounding Pharmacy.[ Price : $8.95]
FDA approves an AbbVie NDA for Orilissa (elagolix), the first oral gonadotropin-releasing hormone antagonist specifically develope...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Inborn Errors of Metabolism That Use Dietary Management: Co...[ Price : $8.95]
FDA publishes a draft guidance on using liquids and soft foods as a drug administration vehicle.[ Price : $8.95]
On the same day Public Citizen filed a lawsuit against it, FDA 7/23 partially grants the activist groups objective: a ban on cesiu...[ Price : $8.95]
FDA posts a draft guidance on Inborn Errors of Metabolism That Use Dietary Management: Considerations for Optimizing and Standardi...[ Price : $8.95]
FDA clears a Medi-Lynx Cardiac Monitoring 510(k) for the PocketECG Cardiac Rehabilitation System, a mobile cardiac rehabilitation ...[ Price : $8.95]
FDA grants Allergan a fast track designation for AGN-241751, an investigational new treatment for major depressive disorder.